593 related articles for article (PubMed ID: 12791812)
41. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
Parkinson Study Group
JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889
[TBL] [Abstract][Full Text] [Related]
42. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
Marek K; Innis R; van Dyck C; Fussell B; Early M; Eberly S; Oakes D; Seibyl J
Neurology; 2001 Dec; 57(11):2089-94. PubMed ID: 11739831
[TBL] [Abstract][Full Text] [Related]
43. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
Tatsch K; Schwarz J; Mozley PD; Linke R; Pogarell O; Oertel WH; Fieber RS; Hahn K; Kung HF
Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093
[TBL] [Abstract][Full Text] [Related]
44. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.
Seibyl JP; Marek KL; Quinlan D; Sheff K; Zoghbi S; Zea-Ponce Y; Baldwin RM; Fussell B; Smith EO; Charney DS; van Dyck C
Ann Neurol; 1995 Oct; 38(4):589-98. PubMed ID: 7574455
[TBL] [Abstract][Full Text] [Related]
45. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
[TBL] [Abstract][Full Text] [Related]
46. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
[TBL] [Abstract][Full Text] [Related]
47. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
[TBL] [Abstract][Full Text] [Related]
48. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
[TBL] [Abstract][Full Text] [Related]
49. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain.
Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ
Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174
[TBL] [Abstract][Full Text] [Related]
50. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
Ahlskog JE; Uitti RJ; O'Connor MK; Maraganore DM; Matsumoto JY; Stark KF; Turk MF; Burnett OL
Mov Disord; 1999 Nov; 14(6):940-6. PubMed ID: 10584667
[TBL] [Abstract][Full Text] [Related]
51. [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.
Tissingh G; Bergmans P; Booij J; Winogrodzka A; Stoof JC; Wolters EC; Van Royen EA
Eur J Nucl Med; 1997 Sep; 24(9):1171-4. PubMed ID: 9283113
[TBL] [Abstract][Full Text] [Related]
52. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour.
Tiihonen J; Kuikka JT; Bergström KA; Karhu J; Viinamäki H; Lehtonen J; Hallikainen T; Yang J; Hakola P
Eur J Nucl Med; 1997 Oct; 24(10):1253-60. PubMed ID: 9323266
[TBL] [Abstract][Full Text] [Related]
53. 123I-beta-CIT SPECT for imaging serotonin transporters in Parkinson's disease.
Barthel H; Hesse S; Sabri O
J Nucl Med; 2004 May; 45(5):923-4. PubMed ID: 15136646
[No Abstract] [Full Text] [Related]
54. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB
J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
[TBL] [Abstract][Full Text] [Related]
55. Effects of ageing on serotonin transporters in healthy females.
Kuikka JT; Tammela L; Bergström KA; Karhunen L; Uusitupa M; Tiihonen J
Eur J Nucl Med; 2001 Jul; 28(7):911-3. PubMed ID: 11504089
[TBL] [Abstract][Full Text] [Related]
56. Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease.
Happe S; Anderer P; Pirker W; Klösch G; Gruber G; Saletu B; Zeitlhofer J
J Neurol; 2004 Dec; 251(12):1465-71. PubMed ID: 15645345
[TBL] [Abstract][Full Text] [Related]
57. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
58. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
[TBL] [Abstract][Full Text] [Related]
59. [123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.
Marek KL; Seibyl JP; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Fussell B; Charney DS; van Dyck C; Hoffer PB; Innis RP
Neurology; 1996 Jan; 46(1):231-7. PubMed ID: 8559382
[TBL] [Abstract][Full Text] [Related]
60. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
